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Abstract
Background: The aim of this study was to clarify the pathogenic mechanism and to evaluate an intervention for
intractable secondary glaucoma in superior vena cava (SVC) syndrome.
Case presentation: A 66-year-old female with underlying hypertension, diabetes mellitus, ischaemic heart disease
and end-stage renal disease complained of bilateral puffy eyelids for 3 months. Over three years, the patient
experienced a progressive, marked face and neck swelling, which was accompanied by dyspnoea and nocturnal
coughing. The patient has been under haemodialysis for the past 5 years; there were several occurrences of
vascular access re-establishment for susceptibility to vascular thrombosis, and she was also diagnosed with SVC
syndrome 2 years after haemodialysis. The patient’s best-corrected visual acuity (BCVA) was 20/60 in the right eye
and 20/400 in the left eye. Pneumatic tonometry revealed a gradual increase in the intraocular pressure (IOP), even
with the use of three types of anti-glaucoma agents. The ratio was 0.7 and bilaterally symmetric; optical coherence
tomography indicated a thinning of the superior and inferior retina nerve fibre layers, and standard automated
perimetry showed partial to generalized depression in both eyes.
Filtering surgery for the left eye was performed, but postoperatively, the IOP increased gradually over three months.
The subsequent placement of the ExPRESS miniature glaucoma device p200 effectively lowered the IOP.
Postoperatively, the IOP of the left eye remained under 20 mmHg without a further decrease in visual acuity, while
the right eye, which was controlled with only medication, had an IOP of greater than 30 mmHg. Because this
patient refused cardiovascular intervention, conventional trabeculectomy was used to redirect the aqueous humour
to the subconjunctival space to form a bleb, but failed. Fortunately, the subsequent ExPRESS implant effectively
facilitated aqueous outflow through the intrascleral space, resulting in the maintenance of a normal IOP at
6 months, postoperatively.
Conclusion: Sustained high IOP may occur after conventional filtration surgery for secondary glaucoma in SVC
syndrome. To facilitate aqueous outflow, an ExPRESS glaucoma implant can be used to effectively control the IOP.
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Background
Even though episcleral vein occlusion has been used to
increase the intraocular pressure (IOP) in an animal
model [1, 2], there are only a few in vivo studies on the
course and management of such cases. Causes of ob-
struction of venous drainage that affect the eyes include
episcleral vein obstruction, orbital disease, cavernous
sinus thrombosis, jugular vein occlusion and superior
vena cava obstruction. In particular, for patients under
chronic haemodialysis, it is not uncommon that superior
vena cava (SVC) syndrome may develop due to venous
stenosis [3, 4].
In SVC syndrome cases, there is an obstruction of
blood flow through the superior vena cava; and dys-
pnoea, chest pain, face edema, neck and eyelid swelling
and ocular hypertension can occur because of the
impaired venous drainage of body fluid. Nevertheless,
Yu et al. previously proposed a classification for SVC
* Correspondence: c571019@cgmh.org.tw; lanhsin.chuang@gmail.com
2Department of Ophthalmology, Chang Gung Memorial Hospital, Keelung.
222 Mai-Chin Rd, Keelung 204, Taiwan, Republic of China
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Ho et al. BMC Ophthalmology  (2016) 16:125 
DOI 10.1186/s12886-016-0301-6
syndrome; according to this report, visual symptoms are
rare, and if visual disturbance by ocular oedema is
present, the disease is graded as being in a moderate
stage [5].
The drainage of the aqueous humour into the venous
system improves the balance of the intraocular pressure
and visual function. A blockade of the venous drainage
is one of the rare causes of glaucoma with elevated
episcleral pressure in SVC syndrome and might not be
noticed due to its subtle ocular manifestation, especially
before and after venous drainage impairment has been
resolved. Thus far, a few case reports on ocular manifes-
tations in SVC syndrome exist, but few studies have
reported treatment for the eyes with elevated episcleral
vein pressure.
Therefore, the purpose of this retrospective study was
to clarify the underlying pathogenic mechanism and to
evaluate the effective interventions of secondary glau-
coma in SVC syndrome. In addition, we will establish
the efficacy and safety of surgical intervention for sec-
ondary glaucoma in SVC syndrome.
Case presentation
A 66-year-old woman presented to our outpatient
services in 2011 with the complaint of progressively
puffy eyelids on both eyes in the most recent 3 months.
Her past medical history showed hypertension, type 2
diabetes mellitus, ischaemic heart disease, and end-stage
renal disease. Additionally, she had been undergoing
haemodialysis three times a week since 2009 (3 years
ago). With the history of chronic haemodialysis, in 2011,
a computed tomography angiography (CTA) revealed an
occlusion of the right subclavian vein at the junction
with the superior vena cava (SVC), and there was a
subtotal occlusion at the SVC orifice in the arteriog-
raphy (Fig. 1b). Progressively, her appearance changed,
with marked oedema of the face and neck, but without
any obvious lymphadenopathy or palpable mass on the
neck (Fig. 1a). Additionally, she experienced dyspnoea
and intermittent nocturnal coughing. The patient received
cataract surgery for both eyes 10 years ago. There was no
use of corticosteroids in her medical records and no
positive family history of glaucoma.
A general inspection revealed the orthotropic primary
ocular position without proptosis. The eyelids were
swollen without tenderness or local heat, and initially,
the intraocular pressure was normal. There was moder-
ate congestion of the conjunctiva in both eyes; the
corneas were clear, and the anterior chambers were deep
and quiet. In 2013, two years after SVC syndrome was
diagnosed, pneumatic tonometry revealed bilateral high
IOP (22 mmHg OD, 23 mmHg OS) compared to a prior
visit. Then, the IOP increased progressively to 30 mmHg,
even with the combined use of brimonidine, dorzola-
mide and latanoprost, which was aimed at controlling
IOP. At that time, the patient’s best-corrected visual acu-
ity (BCVA) was 20/60 in the right eye and 20/400 in the
left eye. Gonioscopy demonstrated wide-open angles in
both eyes without peripheral anterior synechiae or neo-
vascularization of the angle. Upon fundus examination,
the cup-to-disk ratio was found to have increased to 0.7
in both eyes after one and half years of treatment with
an anti-glaucoma agent. Optical coherence tomography
showed the superior and inferior thinning of the retinal
a b
Fig. 1 SVC syndrome occurred several times after repeated implantation of tunnelled double-lumen catheters for haemodialysis. a Gradual
development of SVC syndrome with classic symptoms, including obvious face, neck, and upper trunk swelling. b A reconstructed coronal
section of the contrast enhanced computed tomography angiogram revealed a fibrotic SVC. The occlusion (white arrow) of the right
internal jugular vein at the junction with SVC and accompanying collateral blood-flow network (black arrow) indicated chronic SVC
obstruction. (SVC = superior vena cava)
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nerve fibre layer (RNFL) in both eyes, which was worse
on the left side. Specifically, the patient had an average
RNFL of 65.57 μm in the right eye and 47.51 μm in the
left eye. Standard automated perimetry showed a three-
fourths quadrant depression in the right eye and more
generalized depression in the left eye; the mean devia-
tions were -17.57 and -27.07, respectively.
Due to the progressive course of glaucomatous change,
we suggested that the patient first have filtering surgery
for the left eye. We performed a trabeculectomy, which
resulted in a postoperative IOP reduction (from 30 to
12 mmHg) on the first day. No complications occurred
intraoperatively and none was reported at the one-
month post-operative review. However, over the next
three months, although the filtering bleb significantly
elevated, the intraocular pressure (IOP) increased grad-
ually, reaching approximately 40 mmHg (Fig. 2a). Subse-
quently, this patient received the placement of one
ExPRESS miniature glaucoma device P200 (Fig. 2b),
which resulted in the lowering of the IOP (from 45 to
17 mmHg), and no further deterioration of visual acuity
occurred 6 months after this intervention, while the IOP
of the other eye still ranged between 33 and 35 mmHg.
During the management of intractable secondary glau-
coma, we reviewed the patient’s past medical history and
image data and found that the patient was susceptible to
vascular thrombosis and stenosis, as evidenced by the
high venous pressure observed during haemodialysis,
and while creating the vascular shunt, repeated angio-
plasty and thrombectomy for venous outlet thrombosis
were required. There were multiple attempts at creating
vascular accesses during the initial 2 years. First, a right
neck Hickman catheter was inserted for temporary
haemodialysis access, after which a second was placed in
her right arm, but failed within a short time. Third, an
arteriovenous fistula (AVF) was created in the left arm
with a radial arterial-cephalic vein anastomosis, which
failed in three years and was replaced by an arterioven-
ous graft (AVG) between the brachial artery and the
axillary vein in the left arm after 6 months. The patient
had been under haemodialysis via AVG since then, but
encountered acute occlusion once and received a balloon
percutaneous transluminal angioplasty (PTA). In 2011,
the patient was admitted once for SVC syndrome after
an unsuccessful attempt to place a Hickman catheter
from the right and left internal jugular vein to bypass
the complete obstruction of the right subclavian vein
and right brachiocephalic vein. PTA was performed un-
successfully, despite the spontaneous resolution of
oedema on the left side of the face. However, the patient
presented with intermittent recurrence and indolent face
and neck oedema afterwards. Over the next 3 years,
marked SVCS, accompanied by uncontrollable IOP, led
to irreversible glaucomatous optic neuropathy. Although
femoral double lumen creation and venous bypass con-
struction were suggested as alternative haemodialysis
access routes, along with the ligation of the previous
AVF in the left arm, the patient refused any cardiovascu-
lar surgical options.
Discussion
SVC syndrome due to the obstruction of blood flow oc-
curs most frequently in intrathoracic malignancy, while
SVC syndrome due to intravascular devices, such as in
haemodialysis, is rare [4]. Although SVC syndrome is
usually not life threatening and there is a lack of ran-
domized clinical trials, Yu et al. previously proposed a
classification for SVC syndrome; however, there is no
consensus on the ocular manifestation and management
[5]. Our case, which was graded as 2 according to Yu’s
classification, demonstrated moderate haemodynamic
symptoms, such as oedema of the head, including the
eyelids and neck, without respiratory and neurologic
signs. Although the timepoint of the onset of secondary
glaucoma is unclear, we eventually observed irreversible
visual deterioration.
As this patient would not accept suggestions for fur-
ther interventions for the unmanageable venous occlu-
sion, the IOP increase persisted, even with medication.
Similar to results reported in a review for the management
Fig. 2 ExPRESS shunt placement. The IOP decreased from 45 to 17 mmHg after surgery. a Gradual increase in IOP after the first intervention with
trabeculectomy. b The Express Shunt Mini Glaucoma shunt was placed at 2 o’clock, adjacent to the limbus
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of elevated episcleral pressure [6], conventional antiglau-
coma agents were not beneficial for our patient, who had
unchanged SVC syndrome. Furthermore, after the first
surgical intervention with trabeculectomy, the patient’s
IOP gradually increased after 3 months. ExPRESS was
performed secondarily, and the IOP was stabilized for
6 months, without postoperative complications.
Glaucoma filtration surgery has been a priority surgi-
cal intervention in primary glaucoma for decades. Tra-
beculectomy redirects the aqueous humour to the
subconjunctival space to gradually form a bleb. However,
this has a limited effect in patients with secondary glau-
coma in SVC syndrome with venous drainage impair-
ment. However, our results showed that after primary
filtration surgery failed, the ExPRESS implant effectively
facilitated aqueous outflow through the intrascleral
space, thereby resulting in a normal IOP. In contrast,
the IOP of the other eye, for which the patient refused
any further intervention, remained high, despite treat-
ment with medication.
Conclusions
Secondary glaucoma with elevated episcleral pressure in
SVC syndrome needs attention because the early ocular
symptoms may be subtle. Although no randomized clin-
ical trials for the treatment of elevated episcleral venous
pressure exist, the ExPRESS miniature glaucoma implant
may be an option for IOP control. Optimal management
can thus prevent irreversible vision deterioration.
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